Twentyeight-Seven Therapeutics is a focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases.

Twentyeight-Seven Therapeutics
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.twentyeight-seven.com
Founded2018
Disease Focus
Development Stage
STOCK CODENon Listed
Address700 Main Street, MA, 2139CambridgeUnited States
700 Main Street, MA, 2139
Cambridge
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/twentyeight-seven-therapeutics” connections=”true” suffix=””]